Meeting Banner
Abstract #4472

Molecular effects of various chemotherapeutic agents on choline phospholipid metabolism of triple-negative breast cancer cells

Menglin Cheng 1, Zaver M. Bhujwalla1, and Kristine Glunde1

1Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

The MRS-detected total choline (tCho) signal is a promising non-invasive surrogate marker of chemotherapy response in breast cancer patients. The molecular mechanisms by which common chemotherapeutic drugs affect the tCho signal, consisting of glycerophosphocholine (GPC), phosphocholine (PC), and free choline (Cho), are unknown. We have employed widely used cancer chemotherapeutic drugs including doxorubicin, paclitaxel, and vinorelbine to treat triple-negative human MDA-MB-231 breast cancer cells to elucidate their molecular effects on choline phospholipid metabolism using high-resolution 1H MRS to detect changes in cellular choline metabolite profiles, and quantitative RT-PCR to assess the corresponding changes in the expression levels of choline-metabolizing enzymes.

This abstract and the presentation materials are available to members only; a login is required.

Join Here